Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587359 Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product |
12/24/1996 | US5587307 FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising the femA gene |
12/24/1996 | US5587306 Dna sequences |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587301 DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
12/24/1996 | US5587299 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
12/24/1996 | US5587287 Thermostable polymerase specific antibody-containing DNA amplification composition and kit |
12/24/1996 | CA1338807C Plasmid vector with pectate lyase signal sequence |
12/19/1996 | WO1996041170A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | WO1996040974A1 Improved method of expression cloning |
12/19/1996 | WO1996040955A1 Adenovirus vectors for gene therapy |
12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | WO1996040941A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | WO1996040935A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
12/19/1996 | WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus |
12/19/1996 | WO1996040929A2 Transferrin receptor genes |
12/19/1996 | WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | WO1996040923A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
12/19/1996 | WO1996040918A2 Novel cd40l mutein |
12/19/1996 | WO1996040916A1 Icam-4 materials and methods |
12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | WO1996040909A1 Bone stimulating factor |
12/19/1996 | WO1996040904A1 Secretion leader trap cloning method |
12/19/1996 | WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein |
12/19/1996 | WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
12/19/1996 | WO1996040881A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
12/19/1996 | WO1996040875A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
12/19/1996 | WO1996040874A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
12/19/1996 | WO1996040867A1 Recombinant viral nucleic acids |
12/19/1996 | WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
12/19/1996 | WO1996040788A1 Anti-allergy bispecific molecules |
12/19/1996 | WO1996040785A1 Monospecific antibodies and methods using them |
12/19/1996 | WO1996040776A1 Methods for purifying authentic igf from yeast hosts |
12/19/1996 | WO1996040769A1 Developmentally-regulated endothelial cell locus-1 |
12/19/1996 | WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | WO1996040762A1 Monocyte chemotactic protein-4 |
12/19/1996 | WO1996040758A1 Process for recovering water-insoluble compounds from a fermentation broth |
12/19/1996 | WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
12/19/1996 | WO1996040722A1 Chromosomal expression of heterologous genes in bacterial cells |
12/19/1996 | WO1996040721A1 A cytotoxicity-based genetic selection system (toxsel) |
12/19/1996 | WO1996040719A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | WO1996040718A1 Expression of lipoproteins |
12/19/1996 | WO1996040290A1 Immunological combination compositions and methods |
12/19/1996 | WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells |
12/19/1996 | WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | WO1996040248A1 Transvacular and intracellular delivery of lipidized proteins |
12/19/1996 | WO1996040246A1 Treatment of t cell mediated autoimmune disorders |
12/19/1996 | WO1996040240A1 Helper virus-free aav production |
12/19/1996 | WO1996040231A1 Method for obtaining receptor agonist antibodies |
12/19/1996 | WO1996040227A1 Tumor associated epitopes |
12/19/1996 | WO1996040219A1 Inhibin compositions and methods of enhancing production performance |
12/19/1996 | WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | WO1996040040A2 Thrombin receptor homolog |
12/19/1996 | WO1996039858A1 Monospecific antibodies and methods using them |
12/19/1996 | WO1996039802A1 Hypersensitive response induced resistance in plants |
12/19/1996 | WO1996036722A3 Embedded expression of heterologous proteins |
12/19/1996 | DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded |
12/19/1996 | CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | CA2704354A1 Expression of lipoproteins |
12/19/1996 | CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor |
12/19/1996 | CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor |
12/19/1996 | CA2451969A1 Method of purifying tissue factor pathway inhibitor |
12/19/1996 | CA2450953A1 Method of solubilizing, purifying, and refolding protein |
12/19/1996 | CA2450804A1 Method of solubilizing, purifying, and refolding protein |
12/19/1996 | CA2450800A1 Method of solubilizing, purifying, and refolding protein |
12/19/1996 | CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains |
12/19/1996 | CA2450795A1 Method of refolding tissue factor pathway inhibitor |
12/19/1996 | CA2288401A1 Icam-4 materials and methods |
12/19/1996 | CA2224174A1 Method for obtaining receptor agonist antibodies |
12/19/1996 | CA2224172A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
12/19/1996 | CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | CA2224012A1 Developmentally-regulated endothelial cell locus-1 |
12/19/1996 | CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein |
12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | CA2223610A1 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
12/19/1996 | CA2223494A1 Chromosomal expression of heterologous genes in bacterial cells |
12/19/1996 | CA2223493A1 Recombinant viral nucleic acids |
12/19/1996 | CA2223440A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
12/19/1996 | CA2223303A1 Treatment of t cell mediated autoimmune disorders |
12/19/1996 | CA2223077A1 Thrombin receptor homolog |
12/19/1996 | CA2223041A1 Immunological combination compositions and methods |
12/19/1996 | CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | CA2222947A1 Inhibin compositions and methods of enhancing production performance |
12/19/1996 | CA2222941A1 A cytotoxicity-based genetic selection system (toxsel) |
12/19/1996 | CA2222789A1 Bone stimulating factor |
12/19/1996 | CA2222551A1 Tumor associated epitopes |
12/19/1996 | CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells |